PubRank

K J Bart

Author PubWeight™ 55.57‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Field evaluation of vaccine efficacy. Bull World Health Organ 1985 4.95
2 Rational strategy for rubella vaccination. Lancet 1983 3.61
3 Vaccine-associated paralytic poliomyelitis. United States: 1973 through 1984. JAMA 1987 2.28
4 Continuing measles transmission in students despite school-based outbreak control program. Am J Epidemiol 1985 2.09
5 Appropriate age for measles vaccination in the United States. Dev Biol Stand 1986 1.80
6 Health impact of measles vaccination in the United States. Pediatrics 1985 1.71
7 Outbreak of paralytic poliomyelitis, Taiwan. Lancet 1984 1.68
8 Elimination of indigenous measles from the United States. Rev Infect Dis 1983 1.50
9 Fetal risk associated with rubella vaccine: an update. Rev Infect Dis 1985 1.50
10 Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 1970 1.40
11 Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 1985 1.39
12 An epidemiological assessment of cholera control programs in rural East Pakistan. Int J Epidemiol 1972 1.36
13 Increasing the supply of cadaveric kidneys for transplantation. Transplantation 1981 1.35
14 Major impediments to measles elimination. The modern epidemiology of an ancient disease. Am J Dis Child 1985 1.32
15 Universal immunization to interrupt rubella. Rev Infect Dis 1985 1.25
16 A benefit-cost analysis of a childhood varicella vaccination programme. Postgrad Med J 1985 1.24
17 Measles and rubella: our remaining responsibilities. Am J Public Health 1983 1.23
18 Pertussis epidemic in Oklahoma. Difficulties in preventing transmission. Am J Dis Child 1986 1.23
19 Imported measles in the United States. JAMA 1982 1.23
20 The opportunity and obligation to eliminate rubella from the United States. JAMA 1984 1.20
21 Methods of assessing the impact of congenital rubella infection. Rev Infect Dis 1985 1.10
22 The plaque-neutralization test as a measure of prior exposure to measles virus. J Infect Dis 1987 1.07
23 Measles seroconfirmation using dried capillary blood specimens in filter paper. Pediatr Infect Dis 1984 1.03
24 Prevention of rubella transmission in medical facilities. JAMA 1982 1.03
25 Poliomyelitis in the USA: virtual elimination of disease caused by wild virus. Lancet 1984 0.99
26 Single solution for oral therapy of diarrhoea. Lancet 1976 0.98
27 Prevalence of rubella antibodies in Massachusetts schoolchildren. Am J Epidemiol 1986 0.97
28 Elimination of rubella and congenital rubella from the United States. Pediatr Infect Dis 1985 0.92
29 History of convulsions and use of pertussis vaccine. J Pediatr 1985 0.91
30 Transmission of measles in medical settings. 1980 through 1984. JAMA 1986 0.89
31 Immunity against measles and rubella in Massachusetts schoolchildren. Dev Biol Stand 1986 0.86
32 Cadaveric kidneys for transplantation. A paradox of shortage in the face of plenty. Transplantation 1981 0.86
33 Measles and models. Int J Epidemiol 1983 0.84
34 Isolation of Vibrio cholerae from nightsoil during epidemics of classical and E1 Tor Cholera in East Pakistan. Bull World Health Organ 1970 0.84
35 The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles. Dev Biol Stand 1986 0.84
36 An epidemic of aseptic meningitis, primarily among infants, caused by echovirus 11-prime. Pediatrics 1968 0.83
37 Reduced dose of DTP vaccine. J Pediatr 1985 0.81
38 Measles on campus. J Am Coll Health 1983 0.80
39 A response to the shortage of cadaveric kidneys for transplantation. Transplant Proc 1979 0.79
40 Indicators of mumps immunity and the effect of intradermal antigen and mumps vaccine on antibody level. Am J Epidemiol 1973 0.78
41 Aerosolized measles vaccine--will it open the window? Rev Infect Dis 1983 0.77
42 Disease prevention through immunization: the beginning of health care reform. Public Health Rep 1993 0.76
43 Costs of not eradicating measles. Am J Public Health 1985 0.75
44 Prevention of rubella in hospitals. Am J Infect Control 1983 0.75
45 Impact of measles in the United States. Rev Infect Dis 1983 0.75
46 The immune response to aerosolized measles vaccine. JAMA 1984 0.75
47 Update: immunizations during pregnancy. J Med Soc N J 1984 0.75
48 Status of measles elimination. Pediatr Infect Dis 1983 0.75
49 The current status of immunization principles: recommendations for use and adverse reactions. J Allergy Clin Immunol 1987 0.75
50 More on pertussis. N Engl J Med 1983 0.75
51 Measles and rubella on campus: how far have we come? J Am Coll Health 1985 0.75
52 Vaccine preventable disease on campus. J Am Coll Health 1984 0.75
53 Cholera. Lancet 1970 0.75
54 Measles and rubella on college campuses: the need to act. J Am Coll Health 1983 0.75
55 New vaccines. Int J Epidemiol 1985 0.75
56 Adverse events following immunization with DTP vaccine. Dev Biol Stand 1985 0.75